TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS

Abstract

To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy.

Key facts

NIH application ID

10474939

Project number

272201600017C-P00007-9999-1

Recipient

UNIVERSITY OF ALABAMA AT BIRMINGHAM

Principal Investigator

DAVID KIMBERLIN

Activity code

N01

Funding institute

NIH

Fiscal year

2021

Award amount

$2,579,355

Award type

—

Project period

2016-07-01 → 2026-02-28